EUVIMEDEUVIMED entdecken
Crossref

A Programmable Peptidic Hydrogel Adjuvant for Personalized Immunotherapy in Resected Stage Tumors

Bihan Wu, Juan Liang, Xuejiao Yang, Yu Fang, Nan Kong, Dinghao Chen, Huaimin Wang iD

Journal of the American Chemical Society · 27.03.2024 · 146 (12) · 8585-8597

DOI: 10.1021/jacs.4c00569 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 13.03.2024. Verfasst von Bihan Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Zhejiang University, Hangzhou, Zhejiang 310058, China. Hauptthemen laut MEDLINE: Hydrogels, Neoplasms. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydrogelsNeoplasmsHumansAnimalsMiceImmunotherapyAdjuvants, ImmunologicPeptidesTumor Microenvironment

Substanzen

HydrogelsAdjuvants, ImmunologicPeptides

Autor:innen und Institutionen

  • Department of Chemistry, Zhejiang University, Hangzhou, Zhejiang 310058, China.
  • Department of Chemistry, School of Science, Institute of Natural Sciences, Westlake Institute for Advanced Study, Westlake University, No. 600 Dunyu Road, Hangzhou, Zhejiang 310024, China.
  • Westlake Laboratory of Life Sciences and Biomedicine, 18 Shilongshan Road, Hangzhou, Zhejiang 310024, China.

ORCID-Profile: Huaimin Wang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wu, B., Liang, J., Yang, X., Fang, Y., Kong, N., Chen, D., & Wang, H. (2024). A Programmable Peptidic Hydrogel Adjuvant for Personalized Immunotherapy in Resected Stage Tumors. Journal of the American Chemical Society, 146(12), 8585-8597. https://doi.org/10.1021/jacs.4c00569

Vancouver

Wu B, Liang J, Yang X, Fang Y, Kong N, Chen D, et al. A Programmable Peptidic Hydrogel Adjuvant for Personalized Immunotherapy in Resected Stage Tumors. Journal of the American Chemical Society. 2024;146(12):8585-8597. doi:10.1021/jacs.4c00569

BibTeX
@article{Wu2024,
  author = {Wu, Bihan and Liang, Juan and Yang, Xuejiao and Fang, Yu and Kong, Nan and Chen, Dinghao and Wang, Huaimin},
  title = {A Programmable Peptidic Hydrogel Adjuvant for Personalized Immunotherapy in Resected Stage Tumors},
  journal = {Journal of the American Chemical Society},
  year = {2024},
  volume = {146},
  number = {12},
  pages = {8585--8597},
  doi = {10.1021/jacs.4c00569}
}
Kostenlos starten →